AgriFORCE_new logo-on_white.jpg
AgriFORCE Granted New U.S. Patent for Developmental Automated Growing Systems
June 10, 2024 08:00 ET | AgriFORCE Growing Systems Ltd.
VANCOUVER, British Columbia, June 10, 2024 (GLOBE NEWSWIRE) -- AgriFORCE Growing Systems Ltd. (“the Company”) (NASDAQ: AGRI; AGRIW), an intellectual property (IP) focused AgTech company, announces...
BioCardia-Final-Logo-2016-JPEG.jpg
BioCardia Announces United States Patent Issuance on Intramyocardial Delivery of Cell Aggregates to the Heart Including Minimally Invasive Radial Artery Approach
June 07, 2024 07:00 ET | BioCardia, Inc.
BioCardia announces that the USPTO has granted Patent No: 11,986,611 titled “Radial and Transendocardial Delivery Catheter,” with a 2036 expiration date.
AgriFORCE_new logo-on_white.jpg
AgriFORCE Receives Australian Patent Allowance for Its High Fiber, High Protein Low Carbohydrate Flour and Technology
April 30, 2024 08:30 ET | AgriFORCE Growing Systems Ltd.
VANCOUVER, British Columbia, April 30, 2024 (GLOBE NEWSWIRE) -- AgriFORCE Growing Systems Ltd. (“the Company”) (NASDAQ: AGRI; AGRIW), an intellectual property (IP) focused AgTech company, announces...
indaptus_logo.png
European Patent Office Approves Key Patent for Indaptus Therapeutics’ Platform Technology
January 04, 2024 08:00 ET | Indaptus Therapeutics
NEW YORK, Jan. 04, 2024 (GLOBE NEWSWIRE) -- Indaptus Therapeutics, Inc. (Nasdaq: INDP), a clinical stage biopharma company that utilizes a proprietary killed, non-pathogenic bacteria-based platform...
Aqua_Security_Logo.png
Aqua Security Granted Patent for Innovative Technology to Secure Serverless Container Environments
November 01, 2023 08:00 ET | Aqua Security
BOSTON, Nov. 01, 2023 (GLOBE NEWSWIRE) -- Aqua Security, the pioneer in cloud native security, today announced that it was​​ granted a patent (11762986) for its MicroEnforcer technology to secure...
BioCardia-Final-Logo-2016-JPEG.jpg
BioCardia Announces Helix™ Biotherapeutic Delivery Patent Issuance in Japan
June 08, 2023 07:00 ET | BioCardia, Inc.
SUNNYVALE, Calif., June 08, 2023 (GLOBE NEWSWIRE) -- BioCardia®, Inc. [Nasdaq: BCDA], a company focused on cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary...
BEAM-Logo-Color and Black-Large-576x375.png
Beam Global is Issued a European Patent for Compact Transportation-Configurable EV ARC™ Systems
May 11, 2023 08:00 ET | Beam Global
SAN DIEGO, May 11, 2023 (GLOBE NEWSWIRE) -- Beam Global, (Nasdaq: BEEM, BEEMW), the leading provider of innovative sustainable products and technologies for electric vehicle (EV) charging, energy...
BioCardia-Final-Logo-2016-JPEG.jpg
BioCardia Announces Issuance of Two Patents Related to Technology That Guides Interventional Therapies
April 04, 2023 07:00 ET | BioCardia, Inc.
SUNNYVALE, Calif., April 04, 2023 (GLOBE NEWSWIRE) -- BioCardia®, Inc. [Nasdaq: BCDA], a developer of cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary...
BioCardia-Final-Logo-2016-JPEG.jpg
BioCardia Announces US Patent on Imaging System for Targeting Cardiac Therapies
June 15, 2022 08:00 ET | BioCardia, Inc.
SUNNYVALE, Calif., June 15, 2022 (GLOBE NEWSWIRE) -- BioCardia®, Inc. [Nasdaq: BCDA], a developer of cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary...
Brooklyn logo.jpg
Brooklyn ImmunoTherapeutics Provides Update on Regenerative Medicine Intellectual Property Portfolio
January 13, 2022 08:30 ET | Brooklyn ImmunoTherapeutics, Inc.
NEW YORK, Jan. 13, 2022 (GLOBE NEWSWIRE) -- Brooklyn ImmunoTherapeutics, Inc. (Nasdaq: BTX) (“Brooklyn”), a biopharmaceutical company focused on exploring the role that cytokine, gene editing, and...